Literature DB >> 23522237

Unilateral humoral rejection after reoperative single-lung transplant.

Claude A Beaty1, Alexander Yang, Timothy J George, Peter B Illei, Ashish S Shah.   

Abstract

The role of antibody-mediated rejection in acute and chronic rejection after lung transplantation is poorly understood. We report the case of a prior single-lung transplant recipient undergoing an acute antibody-mediated rejection isolated to her new, contralateral single-lung transplant. A 44-year-old woman 6 years after undergoing a single-lung transplant for idiopathic pulmonary fibrosis underwent a second single-lung transplant for bronchiolitis obliterans syndrome. Despite a negative crossmatch, she subsequently exhibited severe antibody-mediated rejection to her new allograft within 6 days of transplantation. The process of allograft sensitization is dynamic, and further study is warranted to better understand this process.
Copyright © 2013 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23522237      PMCID: PMC4128897          DOI: 10.1016/j.athoracsur.2012.09.089

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  Diagnostic accuracy of solid phase HLA antibody assays for prediction of crossmatch strength.

Authors:  Thomas M Ellis; Jennifer J Schiller; Allan M Roza; David C Cronin; Brian D Shames; Christopher P Johnson
Journal:  Hum Immunol       Date:  2012-04-23       Impact factor: 2.850

2.  Antibody-mediated rejection in lung transplantation: myth or reality?

Authors:  Allan R Glanville
Journal:  J Heart Lung Transplant       Date:  2010-04       Impact factor: 10.247

3.  Hyperacute rejection following lung transplantation.

Authors:  A E Frost; C T Jammal; P T Cagle
Journal:  Chest       Date:  1996-08       Impact factor: 9.410

4.  Desensitization protocol using bortezomib for highly sensitized patients awaiting heart or lung transplants.

Authors:  M Weston; M Rolfe; T Haddad; M Lopez-Cepero
Journal:  Clin Transpl       Date:  2009

5.  Pre-transplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study.

Authors:  Denis Hadjiliadis; Cecilia Chaparro; Nancy L Reinsmoen; Carlos Gutierrez; Lianne G Singer; Mark P Steele; Thomas K Waddell; Robert D Davis; Michael A Hutcheon; Scott M Palmer; Shaf Keshavjee
Journal:  J Heart Lung Transplant       Date:  2005-07       Impact factor: 10.247

6.  Influence of panel-reactive antibody on survival and rejection after lung transplantation.

Authors:  J S Gammie; S M Pham; Y L Colson; A Kawai; R J Keenan; R J Weyant; B P Griffith
Journal:  J Heart Lung Transplant       Date:  1997-04       Impact factor: 10.247

7.  National conference to assess antibody-mediated rejection in solid organ transplantation.

Authors:  Steven K Takemoto; Adriana Zeevi; Sandy Feng; Robert B Colvin; Stanley Jordan; Jon Kobashigawa; Jerzy Kupiec-Weglinski; Arthur Matas; Robert A Montgomery; Peter Nickerson; Jeffrey L Platt; Hamid Rabb; Richard Thistlethwaite; Dolly Tyan; Francis L Delmonico
Journal:  Am J Transplant       Date:  2004-07       Impact factor: 8.086

8.  Acute antibody-mediated rejection after lung transplantation.

Authors:  Matthew R Morrell; G Alexander Patterson; Elbert P Trulock; Ramsey R Hachem
Journal:  J Heart Lung Transplant       Date:  2008-12-04       Impact factor: 10.247

  8 in total
  2 in total

1.  Antibody-mediated Rejection in Lung Transplantation.

Authors:  Hrishikesh S Kulkarni; Bradford C Bemiss; Ramsey R Hachem
Journal:  Curr Transplant Rep       Date:  2015-09-30

2.  Outcome of Extracorporeal Photopheresis as an Add-On Therapy for Antibody-Mediated Rejection in Lung Transplant Recipients.

Authors:  Alberto Benazzo; Nina Worel; Stefan Schwarz; Ulrike Just; Anna Nechay; Christoph Lambers; Georg Böhmig; Gottfried Fischer; Daniela Koren; Gabriela Muraközy; Robert Knobler; Walter Klepetko; Konrad Hoetzenecker; Peter Jaksch
Journal:  Transfus Med Hemother       Date:  2020-05-05       Impact factor: 3.747

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.